Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FR260500 1% gel vs vehicle in facial acne vulgaris
2004-002842-37Phase 2Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing FR260500 1% gel with Vehicle gel (2 arms). Primary endpoint: Primary efficacy and safety endpoints. Started Oct 2004; status: completed.
02
Drugs
FR260500
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2004-002842-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002842-37.